Brind.
  1. The FDA approved Niktimvo, Trump pledged benefits for oil and gas stocks, and several companies reported new HR hires.

Increased patient demand and refills in the US for Incyte as of August 28, 2025.

1 report, 1 independent Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Increased patient demand and refills in the US for Incyte as of August 28, 2025.

Who's involved

What this event is mainly about
Incyte

Keep exploring

Part of

The FDA approved Niktimvo, Trump pledged benefits for oil and gas stocks, and several companies reported new HR hires. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksIncyte (INCY) Up 9.4% Since Last Earnings Report: Can It Continue? A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 9.4% in that time frame, outperforming